Annual Operating Expenses
$8.31 M
-$3.47 M-29.49%
June 30, 2024
Summary
- As of February 8, 2025, ANEB annual total operating expenses is $8.31 million, with the most recent change of -$3.47 million (-29.49%) on June 30, 2024.
- During the last 3 years, ANEB annual operating expenses has risen by +$4.70 million (+129.92%).
- ANEB annual operating expenses is now -29.49% below its all-time high of $11.78 million, reached on June 30, 2023.
Performance
ANEB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.17 M
+$826.40 K+61.65%
September 30, 2024
Summary
- As of February 8, 2025, ANEB quarterly total operating expenses is $2.17 million, with the most recent change of +$826.40 thousand (+61.65%) on September 30, 2024.
- Over the past year, ANEB quarterly operating expenses has increased by +$502.50 thousand (+30.19%).
- ANEB quarterly operating expenses is now -43.17% below its all-time high of $3.81 million, reached on December 31, 2022.
Performance
ANEB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ANEB Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -29.5% | +30.2% |
3 y3 years | +129.9% | +30.2% |
5 y5 years | - | +30.2% |
ANEB Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -29.5% | +129.9% | -43.2% | +102.3% |
5 y | 5-year | -29.5% | +129.9% | -43.2% | +758.8% |
alltime | all time | -29.5% | +129.9% | -43.2% | +758.8% |
Anebulo Pharmaceuticals Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.17 M(+61.7%) |
Jun 2024 | $8.31 M(-29.5%) | $1.34 M(-19.5%) |
Mar 2024 | - | $1.66 M(-39.7%) |
Dec 2023 | - | $2.76 M(+8.5%) |
Sep 2023 | - | $2.54 M(+2.0%) |
Jun 2023 | $11.78 M | $2.49 M(-12.9%) |
Mar 2023 | - | $2.86 M(-24.9%) |
Dec 2022 | - | $3.81 M(+46.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $2.61 M(+12.3%) |
Jun 2022 | $6.83 M(+89.0%) | $2.33 M(+23.7%) |
Mar 2022 | - | $1.88 M(+75.5%) |
Dec 2021 | - | $1.07 M(-31.1%) |
Sep 2021 | - | $1.55 M(-37.4%) |
Jun 2021 | $3.61 M | $2.48 M(+350.0%) |
Mar 2021 | - | $552.10 K(+70.1%) |
Dec 2020 | - | $324.60 K(+28.7%) |
Sep 2020 | - | $252.30 K |
FAQ
- What is Anebulo Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual operating expenses year-on-year change?
- What is Anebulo Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly operating expenses year-on-year change?
What is Anebulo Pharmaceuticals annual total operating expenses?
The current annual operating expenses of ANEB is $8.31 M
What is the all time high annual operating expenses for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual total operating expenses is $11.78 M
What is Anebulo Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, ANEB annual total operating expenses has changed by -$3.47 M (-29.49%)
What is Anebulo Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of ANEB is $2.17 M
What is the all time high quarterly operating expenses for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly total operating expenses is $3.81 M
What is Anebulo Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, ANEB quarterly total operating expenses has changed by +$502.50 K (+30.19%)